Table 3. Associations between colorectal cancer diagnosis and venous thromboembolism stratified by Charlson Comorbidity Index levels, according to earlier (⩽90 days) and later (between 91 days and 5 years) risk periods following colorectal resection, Denmark, 1995–2010.
Comorbidity stratum | Cohort | Subjects | VTE cases | Person-years | SIR (VTE cases/103 person-years)a | Standardised incidence rate difference (95% CI) | Adjustedb hazard ratio (95% CI) | Interaction contrast (95% CI) |
---|---|---|---|---|---|---|---|---|
⩽90 days after CRC resection | ||||||||
No comorbidity | Reference | 124 340 | 48 | 30 556 | 1.8 | 1. ref | 1. ref | 1. ref |
CRC | 25 261 | 148 | 5857 | 26.0 | 24.2 (19.9, 28.5) | 16 (12, 22) | ||
Mild comorbidity | Reference | 32 737 | 20 | 8016 | 2.2 | 1. ref | 1. ref | |
CRC | 6787 | 41 | 1494 | 27.4 | 25.2 (16.5, 33.9) | 11 (6.4, 19) | 1.0 (−8.7, 11) | |
Moderate comorbidity | Reference | 30 014 | 29 | 7304 | 3.5 | 1. ref | 1. ref | |
CRC | 6357 | 36 | 1374 | 23.9 | 20.4 (12.3, 28.4) | 6.7 (4.1, 11) | −3.8 (−13, 5.3) | |
Severe comorbidity | Reference | 4662 | 5 | 1121 | 3.8 | 1. ref | 1. ref | |
CRC | 1265 | 8 | 263 | 24.8 | 21.0 (2.3, 39.7) | 7.0 (2.3, 21) | −3.2 (−22, 16) | |
>90 days after CRC resection | ||||||||
No comorbidity | Reference | 123 644 | 966 | 490 256 | 2.2 | 1. ref | 1. ref | 1. ref |
CRC | 23 108 | 416 | 73 727 | 5.7 | 3.5 (2.9, 4.1) | 2.9 (2.6, 3.2) | ||
Mild comorbidity | Reference | 32 325 | 389 | 115 772 | 3.2 | 1. ref | 1. ref | |
CRC | 5805 | 107 | 17 137 | 6.1 | 2.9 (1.6, 4.1) | 1.9 (1.5, 2.3) | −0.6 (−2.0, 0.7) | |
Moderate comorbidity | Reference | 29 278 | 405 | 96 501 | 4.0 | 1. ref | 1. ref | |
CRC | 5317 | 104 | 14 915 | 7.1 | 3.1 (1.5, 4.6) | 1.7 (1.3, 2.1) | −0.4 (−2.1, 1.3) | |
Severe comorbidity | Reference | 4436 | 91 | 12 465 | 6.7 | 1. ref | 1. ref | |
CRC | 996 | 23 | 2350 | 10.1 | 3.4 (−1.2, 8.0) | 1.4 (0.85, 2.1) | −0.1 (−4.7, 4.5) |
Abbreviations: CI=confidence interval; CRC=colorectal cancer; SIR=standardised incidence rate; VTE=venous thromboembolism.
Age- and sex-standardised incidence rates, using the age and sex distribution of the CRC cohort as the standard.
Adjusted for age on index date (continuous), sex and calendar year of CRC diagnosis.